166 results
Page 2 of 9
6-K
EX-99.1
7ypu1u
18 Oct 23
Current report (foreign)
6:21am
6-K
EX-99.1
tlh iqysvy556c
18 Oct 23
Current report (foreign)
6:20am
6-K
3hmakf voje65l
2 Oct 23
Current report (foreign)
6:17am
6-K
id974mjt2sfyl
28 Sep 23
Current report (foreign)
6:17am
6-K
m6er 2oopdhdhl52um
11 Sep 23
Current report (foreign)
6:50am
6-K
EX-99.1
8vmshe
27 Jul 23
Current report (foreign)
6:05am
6-K
EX-99.1
zepevzxb xmp
6 Jul 23
Current report (foreign)
6:18am
6-K
2kniuie9
28 Jun 23
Current report (foreign)
6:02am
6-K
EX-99.1
oq06b5n7
23 Jun 23
Current report (foreign)
6:13am
6-K
EX-99.1
bjc5mzixh6q
30 May 23
Current report (foreign)
6:19am
6-K
EX-99.1
zbtzqg8rfdzwgn1e248
30 May 23
Current report (foreign)
6:11am
6-K
piwql4 ksnld
17 May 23
Current report (foreign)
6:02am
6-K
vuhsr0y6
11 May 23
Current report (foreign)
6:10am
6-K
t698kq nrc
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
d4nox85
11 May 23
Current report (foreign)
6:07am
6-K
r15 w109ahn8u56s0lyv
30 Mar 23
Current report (foreign)
6:19am
6-K
EX-99.1
1vif3hpug
21 Dec 22
Current report (foreign)
6:01am
6-K
mrj56
21 Dec 22
Current report (foreign)
6:01am
6-K
EX-99.1
bguph5 6a9mj
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am